Answers are grounded in this paper and cite their sources.
Investigates S-layer glycans' function in bacteria, suggesting new biotechnological uses.
S-layers were long regarded as elegant but functionally inert molecular armor. The discovery, three decades ago, that the S-layer of Geobacillus stearothermophilus carries covalently attached glycans overturned this view and inaugurated a new chapter in bacterial cell biology. Since then, the field has expanded in taxonomic scope and mechanistic depth. Complex O -linked glycans have been characterized on bacterial S-layers across Gram-positive Firmicutes , including Paenibacillus alvei , commensal lactobacilli, and the nosocomial pathogen Clostridioides difficile , while the periodontal pathogen Tannerella forsythia has emerged as a landmark organism whose dual-species S-layer bears an O -linked decasaccharide containing terminal non-mammalian nonulosonic acid — a modification directly implicated in evasion of immune surveillance. What has emerged is a picture of remarkable functional versatility. S-layer glycans govern cell morphology, sporulation, epithelial adhesion, biofilm dynamics, and host immune recognition through pattern-recognition receptors, including DC-SIGN and Mincle. In terms of chemical complexity, they deploy an extraordinary repertoire of rare, taxonomically restricted monosaccharides — among them bacillosamine, pseudaminic acid, and 2,3-cyclophosphoryl-rhamnose — assembled through linkages exceeding the structural diversity of any eukaryotic glycan class. This modularity opens compelling avenues for glycosylation engineering: rewiring transferase specificity or swapping biosynthetic modules could tailor glycan composition for epitope display, self-assembling glyconanostructures, or targeted therapeutic carbohydrate delivery. Cryo-electron tomography and intact glycopeptide mass spectrometry are resolving glycan positioning at near-atomic resolution, while AlphaFold3 is modeling glycan–protein contacts driving lattice stabilization. S-layer glycans represent compelling targets for next-generation antimicrobials, mucosal vaccines, and precision bacteriocins. Their full biological and biotechnological repertoire remains to be uncovered.
No takes yet. Share an insight, caveat, or question.
Christina Schäffer (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: